Immitra Bio
Immitra Bio
Immitra Bio
Scalable, one-time curative in-vivo gene editing therapies.
About
Immitra Bio is developing a scalable, in-vivo gene editing platform designed to offer a single, off-the-shelf injection to cure rare genetic diseases. Their mission is to provide accessible, curative genetic medicine for the 400 million people worldwide affected by these conditions, addressing the limitations of current ex-vivo therapies. Teams look it up for Biotechnology, Gene Therapy, Genetics.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
